https://www.selleckchem.com/products/2-nbdg.html
Although both neoadjuvant chemoradiotherapy (nCRT) and chemotherapy (nCT) are used as neoadjuvant treatment for oesophageal cancer, it is unknown whether one provides a survival advantage over the other, particularly with respect to histological subtype. This study aimed to compare prognosis after nCRT and nCT in patients undergoing oesophagectomy for oesophageal adenocarcinoma (OAC) or squamous cell carcinoma (OSCC). Data from the National Cancer Database (2006-2015) were used to identify patients with OAC and OSCC. Propensity score mat
Like
Comment
Share
